Profarma Recalls Vermox Tablets Due to Manufacturing Deviations
Profarma Distributors LLC is recalling 163 boxes of Vermox Tablets 100 mg due to CGMP deviations. The recall is voluntary and nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which is a reasonable probability of temporary or medically reversible adverse health consequences. The source cites CGMP deviations without reporting specific illnesses or injuries, fitting the criteria for a moderate severity voluntary recall.
Plain-English summary
Profarma Distributors LLC is voluntarily recalling 163 boxes (978 tablets) of VERMOX Tablets 100 mg, 6-count boxes. The specific lot number is UPE187 with an expiration date of 08/17. The product was distributed nationwide.
The recall was initiated because of Current Good Manufacturing Practice (CGMP) deviations. This indicates that the product may not have been manufactured in accordance with FDA regulations regarding quality and safety controls. The recall was initiated on May 11, 2016, and was classified as Class II by the FDA.
Consumers who have this product should stop using it and contact Profarma Distributors LLC for instructions on how to return the product or obtain a refund. The recall was terminated on January 24, 2017.
The recalled product
- Product
- VERMOX Tablets 100 mg; 6-count box, UPC 7501109900619
- Manufacturer
- Profarma Distributors LLC
- Category
- Drug — Antiparasitic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # UPE187
- Exp. 08/17
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 5 recalled by Profarma Distributors LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 5 products in this recall →Related recalls
Same manufacturer · Profarma Distributors LLC
See all →- ModerateProfarma Recalls Vermox Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin ACTIVE M.R. Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls tabcin NOCHE Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
- ModerateProfarma Recalls 1% Clotrimazole Cream Due to Manufacturing Deviations
FDA (Drugs) · 2016-06-29
Same hazard · cgmp deviation
See all →- SevereZicam Cold Remedy Nasal Swabs Recalled for Microbiological Testing Failures
FDA (Drugs) · 2026-09-02
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- SevereShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- ModerateShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19
- HighShoolin Pharma Recalls Tadalafil USP Due to CGMP Deviations
FDA (Drugs) · 2026-08-19